The ABPI welcomes today's publication of the first National Audit Office report on the commissioning of specialised services in the NHS in England.
26 Apr 2016 Posted in By Paul Catchpole
The National Audit Office makes six recommendations including the need for NHS England to develop a clear vision for specialised services, to make decisions in a more streamlined and transparent fashion and manage its budget in a more sustainable way.
New medicines developed by the pharmaceutical industry provide the opportunity to dramatically transform patient outcomes for specialised services through the prevention, treatment and cure of previously life-threatening diseases.
Paul Catchpole, Director of Value and Access at the ABPI, commented:
"As the report highlights, there are an increasing number of effective new specialised treatments becoming available, many for previously untreatable conditions. NHS England must do all it can to make these treatments available to patients by ensuring its new decision-making process is transparent, rapid and predictable.
"The ABPI wants to support the NHS in being at the forefront of improving patient care and outcomes, and supports the report's recommendations, including the development of an overarching strategy for specialised commissioning putting in place clearer governance arrangements and a robust and more transparent decision-making process to prioritise access to treatments.
"This should help reduce variations across England in accessing treatments making it simpler for patients to get the medicines they need. ABPI and the pharmaceutical industry look forward to working with the Department of Health, NHS England and NICE on future arrangements for creating sustainable access mechanisms for new specialised medicines."